Cheatography
https://cheatography.com
.............................
This is a draft cheat sheet. It is a work in progress and is not finished yet.
Insulin secretagogues
Sulfonylureas & meglitinides |
DPP-4 inhibitors |
MOA: block ATP-dependent K+ channels |
Sitagliptin "januvia" |
SU |
MOA: inhibit DPP4 enzyme (cytoplasmic receptor)--> no incretin (GLP1) degredation--> Increase in GLP1 stimulates insulin secretion. |
1 gen: Tolbutamide-chlorpropamide. long acting SU so long hypoglycemic episodes. Only eliminated renallly; risk to renally compromised patients. |
2 gen: Gliclazide-glyburide "glibenclamide" Shorter acting SU with pendant lipohilic gp larger or aromatic. Undergo enterhepatic circulation and eliminated in urine & bile. |
3 gen: Glimepiride Completely metabolized by oxidation of pendant methyl substituent into methoxy metabolites (mostly in feces) & COOH metabolites (mostly in urine). |
Meglitinides/glitinides |
D-phenylalanine-Repaglinide-Nateglinide |
|
|
Insulin sensitizers
Biguanides |
Thiazolidinediones (TZD) |
Metformin |
Rosiglitazone-Pioglitazone |
MOA: reduces liver glucose release and increases glucose uptake into tissue (decreases BG level). |
MOA: activate the nuclear receptors (PPAR-y) which causes transcription of genes stimulating lipid uptake & adipogenesis. |
Best described as anti-hyperglycemic agent because it doesn't cause hypoglycemia. |
1st line for T2D with normal kidney function (Ineffective without insulin). |
Alpha-glucosidase inhibitors
Voglibose |
MOA: Delay digestion and carb absorption. |
SE: flatulence, bloating, abdominal cramping |
Adjuvant therapy. |
|